PCOS Diagnostic Market Size is predicted to witness a 5.0% CAGR during the forecast period for 2025-2034.
PCOS (polycystic ovarian syndrome) is a hormonal condition affecting many women of reproductive age. PCOS is characterized by irregular or prolonged menstrual cycles as well as high levels of male hormones. Although there is no cure for PCOS, various medications are used to regulate the menstrual cycle and manage the condition's symptoms. It is also caused by high levels of androgens, low-grade inflammation, ovarian cysts, too much insulin, and hereditary abnormalities. The polycystic ovarian syndrome diagnostic industry is growing due to increased PCOS prevalence, patient awareness, and increased usage of combination therapy. Furthermore, simple access to PCOS treatments, rising demand for PCOS drugs, and technical developments in PCOS screening all have an impact on market growth.
However, the COVID-19 outbreak had a huge influence on the healthcare industry. The polycystic ovarian syndrome (PCOS) therapy market is not immune to the pandemic's consequences, which impacted various surgical procedures, including laparoscopic ovarian drilling. To combat the COVID-19 pandemic, various governments-imposed lockdown and social distancing restrictions, which resulted in the suspension of multiple operations, supply chain disruptions, stifling business growth, and the shutdown of new developments, which had a negative impact on the market.
The PCOS diagnostic market is segmented on the basis of test type and end user. Based on test type, the market is segmented as blood tests, pelvic exams, and ultrasound (transvaginal). The end-user segment includes hospitals & clinics, fertility clinics, and others.
The ultrasound (transvaginal) category is expected to hold a major share of the global PCOS diagnostic market in 2022. This can be attributable to the fertility issues that women suffer as a result of this illness, as well as the fact that women's responses to drugs often wane over time. Furthermore, this process is inexpensive and simple to carry out, propelling the segment's rise worldwide.
The hospitals & clinics segment is projected to increase in the global PCOS due to the rising frequency of PCOS and associated operations that are performed more frequently in hospital settings. Hospitals are the first choice for diagnosing and treating PCOS. Because no single test can specifically diagnose polycystic ovarian syndrome (PCOS), clinicians must first diagnose PCOS patients. The doctor or patient's health care provider will most likely begin by discussing their symptoms, medications, and any other medical conditions they may be experiencing. The doctor may also ask about menstrual cycles and weight swings. Search for signs of acne, insulin resistance, and excessive hair growth during a physical exam.
The North American PCOS Diagnostic Market is expected to register the highest market share in revenue in the near future. The rising prevalence of obesity and overweight is increasing the number of people suffering from PCOS, which is one of the primary reasons driving market expansion in North America. Furthermore, increased knowledge of the benefits of frequent checkups is contributing to an increase in the number of new cases detected in this region each year.
Moreover, Europe is expected to grow at a significant rate. These governments are working on reducing the rising prevalence of PCOS by implementing programs that assist PCOS diagnosis and treatment, as well as the necessary lifestyle changes. These programs are raising awareness about PCOS and its related concerns, such as the development of insulin resistance, obesity, and, in some circumstances, infertility.
|
Report Attribute |
Specifications |
|
Growth rate CAGR |
CAGR of 5.0% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Test Type And End User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Siemens Healthineers AG, GE Healthcare, Mindray Medical International Limited, Esaote S.p.A, Telemed Medical Systems, Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI), BK Medical, Alpinion Medical Systems, Mindray ZONARE Medical Systems, and Xianfeng Ultrasound Medical |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Peripheral Vascular Devices Market Snapshot
Chapter 4. Global Peripheral Vascular Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Test Type Estimates & Trend Analysis
5.1. by Test Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Test Type:
5.2.1. Blood Tests
5.2.2. Pelvic Exam
5.2.3. Ultrasound (Transvaginal)
Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-users:
6.2.1. Hospitals & Clinics
6.2.2. Fertility clinics
6.2.3. Others
Chapter 7. Peripheral Vascular Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2021-2034
7.1.2. North America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.1.3. North America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2021-2034
7.2.2. Europe Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.2.3. Europe Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2021-2034
7.3.2. Asia Pacific Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.3.3. Asia Pacific Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2021-2034
7.4.2. Latin America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.4.3. Latin America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2021-2034
7.5.2. Middle East & Africa Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.5.3. Middle East & Africa Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Siemens Healthineers AG
8.2.2. GE Healthcare
8.2.3. Mindray Medical International Limited
8.2.4. Esaote S.p.A
8.2.5. Telemed Medical Systems
8.2.6. Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
8.2.7. BK Medical
8.2.8. Alpinion Medical Systems
8.2.9. Mindray ZONARE Medical Systems
8.2.10. Xianfeng Ultrasound Medical
8.2.11. Other Prominent Players
PCOS Diagnostic Market By Test Type-
PCOS Diagnostic Market By End User-
PCOS Diagnostic Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
